Ashok Srivastava
Global Leader of Metastatic Hematology/Oncology, Rare Dis. CAR-T, ADC, Oncolyticviro therapy, Tumor Board Member, Clin. Dev Med/Safety Monitor, file IND/NDA/BLA to FDA/EMA/PMDA. Chief Clinical Officer, USA. Patients Care
- Role
- Clinical Officer, Car-t Cell Therapy Relapsed Refractory Leukemia Lymphoma at Autolus Therapeutics
- Location
- New York, NY, US
- LinkedIn followers
- 500 followers
About Ashok Srivastava
Dr. Ashok Srivastava, MD, Ph.D, MBA, is the clinical leader of pediatric and adult…
Experience
Clinical Officer, Car-t Cell Therapy Relapsed Refractory Leukemia Lymphoma
Jul 2023 — Present · London, GB
CAR-T cell therapy of lymphoma and leukemia.Highly active T cell therapies for cancer.An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaA Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Clinical and safety data review and BLA submissionSafety and efficacy of a CAR-T cell treatment targeting CD19, in adult patients with relapsed or refractory B cell Acute Lymphoblastic Leukemia.Pre-BLA meeting with FDAFile BLAFDA Inspection readiness
Education
Nagasaki University
Doctor of Medicine - MD, School of Medicine, Nagasaki University, Nagasaki, Japan , Medicine
Rutgers University
Executive MBA, Pharmaceutical Business Management, Rutgers University, New Jersey, USA
School of Medicine Nagasaki University, Japan; All India Institute of Medical Science New Delhi India; Rutgers U. Business, NJ, USA;
MD, Ph.D., MBA, Medical Oncology and Hematology
1990 — 2003
Tufts University
Tufts Center for the Study of Drug Development , Tufts Center for the Study of Drug Development
Georgetown University School of Medicine
Fellwoship Clinical Pharmacology
All India Institute of Medical Sciences
Medicine
ESMO
Oncology
Harvard University
Artificial intelligence in Healthcare
Accreditation Council for Medical Affairs, New York, NY, Year, USA
Professional Certification in Medical Affairs Oncology Board , Oncology, Hematology and Immuno-Oncology- 2017
Harvard University
Clinical and Medical oncology, Medical Oncology at Dana Farber Cancer Center
2017 — 2020
University Hospital Kralovske Vinohrady at Prague Prague
Ph.D., Immunology, Onco-virology, Czechoslovak Acadamey of Medical Sciences, Prague, Czechoslovakia, Infectious Diseases
United Nations
Medical Officer, Pediatric Health Care in Europe
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.